Amyloid: little proteins, big clues - PubMed (original) (raw)

. 2011 Jul 13;475(7355):S12-4.

doi: 10.1038/475S12a.

• PMID: 21760575
• DOI: 10.1038/475S12a

Amyloid: little proteins, big clues

Jim Schnabel. Nature. 2011.

No abstract available

PubMed Disclaimer

Similar articles

• Dynamics of plaque formation in Alzheimer's disease.
  Urbanc B, Cruz L, Buldyrev SV, Havlin S, Irizarry MC, Stanley HE, Hyman BT. Urbanc B, et al. Biophys J. 1999 Mar;76(3):1330-4. doi: 10.1016/S0006-3495(99)77295-4. Biophys J. 1999. PMID: 10049316 Free PMC article.
• Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
  Baier M, Apelt J, Riemer C, Gültner S, Schwarz A, Bamme T, Burwinkel M, Schliebs R. Baier M, et al. Int J Dev Neurosci. 2008 Nov;26(7):821-4. doi: 10.1016/j.ijdevneu.2008.07.001. Epub 2008 Jul 9. Int J Dev Neurosci. 2008. PMID: 18662767
• Medicine. Prion-like behavior of amyloid-beta.
  Kim J, Holtzman DM. Kim J, et al. Science. 2010 Nov 12;330(6006):918-9. doi: 10.1126/science.1198314. Science. 2010. PMID: 21071652 No abstract available.
• [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
  Asai M, Kawakubo T, Mori R, Iwata N. Asai M, et al. Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2. Yakugaku Zasshi. 2017. PMID: 28674290 Review. Japanese.
• Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases.
  Díaz-Nido J, Wandosell F, Avila J. Díaz-Nido J, et al. Peptides. 2002 Jul;23(7):1323-32. doi: 10.1016/s0196-9781(02)00068-2. Peptides. 2002. PMID: 12128089 Review.

Cited by

• Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease.
  Clark IA, Vissel B. Clark IA, et al. Br J Pharmacol. 2015 Aug;172(15):3714-27. doi: 10.1111/bph.13181. Epub 2015 Jun 29. Br J Pharmacol. 2015. PMID: 25939581 Free PMC article. Review.
• Facing up to Complexity: Implications for Our Social Experiments.
  Hawkins R. Hawkins R. Sci Eng Ethics. 2016 Jun;22(3):775-814. doi: 10.1007/s11948-015-9657-x. Epub 2015 Jun 11. Sci Eng Ethics. 2016. PMID: 26062747
• Real-time monitoring of the amyloid β1-42 monomer-to-oligomer channel transition using a lipid bilayer system.
  Numaguchi Y, Tsukakoshi K, Takeuchi N, Suzuki Y, Ikebukuro K, Kawano R. Numaguchi Y, et al. PNAS Nexus. 2023 Dec 14;3(1):pgad437. doi: 10.1093/pnasnexus/pgad437. eCollection 2024 Jan. PNAS Nexus. 2023. PMID: 38156289 Free PMC article.
• Synapse-binding subpopulations of Aβ oligomers sensitive to peptide assembly blockers and scFv antibodies.
  Velasco PT, Heffern MC, Sebollela A, Popova IA, Lacor PN, Lee KB, Sun X, Tiano BN, Viola KL, Eckermann AL, Meade TJ, Klein WL. Velasco PT, et al. ACS Chem Neurosci. 2012 Nov 21;3(11):972-81. doi: 10.1021/cn300122k. Epub 2012 Oct 23. ACS Chem Neurosci. 2012. PMID: 23173076 Free PMC article.
• Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model.
  Jiao SS, Bu XL, Liu YH, Zhu C, Wang QH, Shen LL, Liu CH, Wang YR, Yao XQ, Wang YJ. Jiao SS, et al. Neurotox Res. 2016 Feb;29(2):256-66. doi: 10.1007/s12640-015-9589-x. Epub 2015 Dec 26. Neurotox Res. 2016. PMID: 26707129

References

1. 1. Science. 2010 Nov 12;330(6006):980-2 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information